These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Development of ocular motility following modified 3-wall decompression of the orbita in endocrine orbitopathy for functional and rehabilitative indication]. Grenzebach UH, Schnorbus U, Büchner T, Busse H, Stoll W. Klin Monbl Augenheilkd; 2003 May; 220(5):345-51. PubMed ID: 12766824 [Abstract] [Full Text] [Related]
6. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Ronco P, Plaisier E, Mougenot B, Aucouturier P. Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367 [Abstract] [Full Text] [Related]
7. Extraocular muscle enlargement after orbital decompression for Graves' ophthalmopathy. Wenz R, Levine MR, Putterman A, Bersani T, Feldman K. Ophthalmic Plast Reconstr Surg; 1994 Mar; 10(1):34-41. PubMed ID: 8193071 [Abstract] [Full Text] [Related]
8. The combination of thrombotic microangiopathy and nodular sclerosis in light chain deposition disease. Kanjanabuch T, Bunruang R, Srisawat N, Lewsuwan S, Kittikovit V, Eiam-Ong S. J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S248-52. PubMed ID: 17044479 [Abstract] [Full Text] [Related]
9. Endoscopic orbital decompression for Graves' ophthalmopathy. Levy J, Puterman M, Lifshitz T, Marcus M, Segal A, Monos T. Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804 [Abstract] [Full Text] [Related]
10. [Light chain deposition disease (LCDD), light and heavy chain deposition disease (LHCDD)]. Akashi Y, Yoshizawa N. Ryoikibetsu Shokogun Shirizu; 1997 Nov; (17 Pt 2):314-7. PubMed ID: 9277926 [No Abstract] [Full Text] [Related]
13. Immunohistochemical staining of normal and Graves' extraocular muscle. Tallstedt L, Norberg R. Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263 [Abstract] [Full Text] [Related]
14. Dysthyroid optic neuropathy without extraocular muscle involvement. Anderson RL, Tweeten JP, Patrinely JR, Garland PE, Thiese SM. Ophthalmic Surg; 1989 Aug; 20(8):568-74. PubMed ID: 2779967 [Abstract] [Full Text] [Related]
15. Ultrasonic B-scan measurement of the extra-ocular muscles in Graves' orbitopathy. Willinsky RA, Arenson AM, Hurwitz JJ, Szalai J. J Can Assoc Radiol; 1984 Jun; 35(2):171-3. PubMed ID: 6384227 [Abstract] [Full Text] [Related]
16. Maximal, three-wall, orbital decompression through a coronal approach. Goldberg RA, Weinberg DA, Shorr N, Wirta D. Ophthalmic Surg Lasers; 1997 Oct; 28(10):832-43. PubMed ID: 9336777 [Abstract] [Full Text] [Related]
17. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD. J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577 [Abstract] [Full Text] [Related]
18. Preliminary report: long-term results of transnasal orbital decompression in malignant Graves' ophthalmopathy. Michel O, Oberländer N, Neugebauer A, Fricke J, Rüssmann W. Strabismus; 2000 Jun; 8(2):113-8. PubMed ID: 10980692 [Abstract] [Full Text] [Related]
19. Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease. Brioli A, Zamagni E, Pasquali S, Tosi P, Tacchetti P, Perrone G, Pantani L, Petrucci A, Zannetti BA, Baccarani M, Cavo M. Bone Marrow Transplant; 2012 Sep; 47(9):1248-9. PubMed ID: 22231462 [No Abstract] [Full Text] [Related]
20. High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease. Hassoun H, Flombaum C, D'Agati VD, Rafferty BT, Cohen A, Klimek VM, Boruchov A, Kewalramani T, Reich L, Nimer SD, Comenzo RL. Bone Marrow Transplant; 2008 Sep; 42(6):405-12. PubMed ID: 18574442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]